Free Access
Issue |
Med Sci (Paris)
Volume 19, Number 3, Mars 2003
|
|
---|---|---|
Page(s) | 327 - 336 | |
Section | M/S Revues | |
DOI | https://doi.org/10.1051/medsci/2003193327 | |
Published online | 15 March 2003 |
- Demoly P, Messaad D, Benahmed S, et al. Les réactions immunoallergiques d’origine médicamenteuse: données épidémiologiques et cliniques. Therapie 2000; 55: 13–21. [Google Scholar]
- Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998; 279: 1200–5. [Google Scholar]
- Imb JL, Pouyanne P, Haramburu F, et al. Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Therapie 1999; 54: 21–7. [Google Scholar]
- Bigby M, Jick S, Jock H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston collaborative drug surveillance program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358–63. [Google Scholar]
- Smith JW, Johnson JEIII, Cliff LE. Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy. N Engl J Med 1966; 274: 998–1002. [Google Scholar]
- Ibia EO, Schwartz RH, Wiedermann BL. Antibiotic rashes in children. Arch Dermatol 2000; 136: 849–54. [Google Scholar]
- Burke P, Burne SR. Allergy associated with ciprofloxacin. Br Med J 2000; 320: 679. [Google Scholar]
- Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621–8. [Google Scholar]
- Laxenaire MC. Épidémiologie des réactions anaphylactoides peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 1999; 18: 796–809. [Google Scholar]
- Roujeau JC, Stern RS. Severe cutaneous adverse reactions to drugs. N Engl J Med 1994; 331: 1272–85. [Google Scholar]
- Lenler-Petersen P, Hansen D, Andersen M, et al. Drugrelated fatal anaphylactic shock in Denmark 1968- 1990. A study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol 1995; 48: 1185–8. [Google Scholar]
- Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. Br Med J 2000; 320: 1441. [Google Scholar]
- International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 1991; 337: 1308–10. [Google Scholar]
- Lafaye P, Lapresles C. Fixation of penicilloyl groups to albumin and appearance of antipenicilloyl antibodies in penicillin-treated patients. J Clin Invest 1988; 82: 7–12 [Google Scholar]
- Haddi E, Charpin D, Tafforeau M, et al. Atopy and systemic reactions to drugs. Allergy 1990; 45: 236–9. [Google Scholar]
- Romano A, De Santis A, Romito A, et al. Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. Ann Allergy Asthma Immunol 1998; 80: 433–7. [Google Scholar]
- Kowalski ML, Woszczek G, Bienkiewicz B, Mis M. Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy 1998; 28: 1353–8. [Google Scholar]
- Vittorio CC, Muglia JJ. Anticonvulsiviant hypersensitivity syndrome. Arch Intern Med 1995; 155: 2285–90. [Google Scholar]
- Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670–4. [Google Scholar]
- Asero R. Detection of patients with multiple drug allergy syndrome by elective tolerance tests. Ann Allergy Asthma Immunol 1998; 80: 185–8. [Google Scholar]
- Khoury L, Warrington R. The multiple drug allergy syndrome: a matchedcontrol retrospective study in patients allergic to penicillin. J Allergy Clin Immunol 1996; 98: 462–4. [Google Scholar]
- Zanni MP, von Greyerz S, Scnyder B, Wendland T, Pichler WJ. HLA-restricted, processing- and metabolism independent pathway of drug recognition by human αβ T lymphocytes. J Clin Invest 1998; 102: 1591–8. [Google Scholar]
- Rieder MJ, Uetrcht J, Shear NH, Cannon M, Miller M, Spielberg SP. Diagnosis of sulfonamide hypersensitivity reactions by in vitro rechallenge with hydroxylamine metabolites. Ann Intern Med 1989; 110: 286–9. [Google Scholar]
- Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986; 105: 179–84. [Google Scholar]
- Carr A, Gross AS, Hoskins JM, Penny R, Cooper DA. Acetylation phenotype and cutaneous hypersensitivity to trimethoprimsulphamethoxazole in HIVinfected patients. AIDS 1994; 8: 333–7. [Google Scholar]
- Wolkenstein P, Carriere V, Charue D, et al. A slow acetylator genotype is a risk factor for sulfonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome. Pharmacogenetics 1995; 5: 255–8. [Google Scholar]
- Naisbitt DJ, Vilar J, Stalford A, et al. Plasma cysteine and decreased reduction of nitroso sulphamethoxazole with HIV infection. AIDS Res Hum Retrovir 2000; 16: 1929–38. [Google Scholar]
- Buhl R, Jaffe HA, Holroyd KJ, et al. Systemic glutathion deficiency in symptom free HIVseropositive individuals. Lancet 1989; 334: 1294–8. [Google Scholar]
- Roujeau JC. Toxidermies médicamenteuses: quelques nouveautés. Rev Fr Allergol Immunol Clin 2002; 42: 71–4. [Google Scholar]
- Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct, MHCdependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 1997; 100: 136–41. [Google Scholar]
- Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995; 155: 462–72. [Google Scholar]
- Zanni MP, von Greyerz S, Schnyder B, Wendland T, Pichler WJ. HLAunrestricted presentation of lidocaine by HLA-DR molecules to specific αβ+ T cell clones. Immunol Int 1998; 10: 507–15. [Google Scholar]
- Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in druginduced acute generalized exanthematous pustulosis. J Clin Invest 2001; 107: 1433–41. [Google Scholar]
- Zanni MP, Mauri-Hellweg D, Brander C, et al. Characterization of lidocaine specific T cells. J Immunol 1997; 158: 1139–48. [Google Scholar]
- Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490–3. [Google Scholar]
- Hari Y, Frutig-Schnyder K, Hurni M, et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31: 1198–408. [Google Scholar]
- Blanca M, Posadas SJ, Torres MJ, et al. Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous drug reactions. Allergy 2000; 55: 998–1004. [Google Scholar]
- Posadas SJ, Leyva L, Torres MJ, et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reactions. J Allergy Clin Imunol 2000; 106: 769–76. [Google Scholar]
- Weltzien HU, Padovan E. Molecular features of penicillin allergy. J Invest Dermatol 1998; 110: 203–6. [Google Scholar]
- Barbaud A, Béné MC, Reichert-Penetrat S, Jacquin-Petit MA, Schmutz JL, Faure GC. Immunocompetent cells and adhesion molecules in 14 cases of cutaneous drug reactions induced with the use of antibiotics. Arch Dermatol 1998; 134: 1040–1. [Google Scholar]
- Hertl M, Bohlen H, Jugert F, Merk HF. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by β-lactam antibiotics. J Invest Dermatol 1993; 101: 794–9. [Google Scholar]
- Reilly TP, Lash LH, Doll MA, et al. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 2000; 114: 1164–73. [Google Scholar]
- Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity questionnaire. Allergy 1999; 54: 999–1003. [Google Scholar]
- Brochow K, Romano A, Blanca M, Ring J, Pichler WJ, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2003 (sous presse). [Google Scholar]
- Barbaud A. Gonçalo M, Bruynzeel D, Bircher A. Guidelines for skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321–8. [Google Scholar]
- Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Therapie 1985; 40: 111–4. [Google Scholar]
- Guilloux L, Ricard-Blum S, Ville G, Motin J. Histamine release assay and radioimmunoassay for the detection of IgE antibodies against neuromuscular blocking drugs. Ann Fr Anesth Reanim 1993; 12: 182–6. [Google Scholar]
- Lebel B, Messaad D, Kvedariene V, Rongier M, Bousquet J, Demoly P. Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 2001; 56: 688–92. [Google Scholar]
- Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27: 175–81. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.